Litcius/Paper detail

Haematological and Inflammatory Biomarkers Among Stable COPD and Acute Exacerbations of COPD Patients

Ramya Priya A, Madhusmita Mohanty Mohapatra, Vinod Kumar Saka, Rakhee Kar, Sunitha Vellathussery Chakkalakkoombil, Mahesh Babu Vemuri

2022Sultan Qaboos University medical journal11 citationsDOIOpen Access PDF

Abstract

Objectives: Chronic Obstructive Pulmonary Disease (COPD) is heterogeneous in nature. Acute exacerbation of COPD (AECOPD) is diagnosed clinically which is subjective and clinical judgment may vary from clinician to clinician. Since chronic inflammation underlies the pathogenesis of COPD, markers of inflammation have generated lot of interest for their potential to be used as biomarkers of COPD. This study aimed to assess the variation in levels of neutrophil lymphocyte ratio (NLR) and platelet indices in patients with stable COPD and acute exacerbation of COPD patients and its association with GOLD stages. Methods: This prospective analytical study was carried out in our tertiary care hospital from December 2018 to July 2020. About 64 subjects (32- stable COPD, 32- AECOPD) who satisfied study criteria were included. Blood sample was taken from stable and AECOPD patients and were compared. Results: It was observed that Neutrophil Lymphocyte Ratio, Platelet Distribution Width, Erythrocyte Sedimentation Rate and C-Reactive Protein were increased in AECOPD patients when compared with stable COPD patients which was statistically significant with p value of Conclusion: We found that neutrophil lymphocyte ratio and platelet distribution width values increased significantly in AECOPD patients when compared to stable COPD patients. Keywords: AECOPD; COPD; Neutrophil Lymphocyte Ratio; Platelet Distribution Width.

Topics & Concepts

MedicineCOPDErythrocyte sedimentation rateInternal medicineExacerbationNeutrophil to lymphocyte ratioProspective cohort studySystemic inflammationRed blood cell distribution widthGastroenterologyPathogenesisInflammationLymphocyteImmunologyInflammatory Biomarkers in Disease PrognosisChronic Obstructive Pulmonary Disease (COPD) ResearchInflammation biomarkers and pathways